semaglutide patent expiry india With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are Semaglutide Patent Expiry in 2026:

Insurers approve cases where the medication addresses multiple conditions, not just weight

A degraded semaglutide molecule cannot bind to GLP-1 receptors properly, which means reduced efficacy or no efficacy at all

The other is the use of an acid-resistant capsule designed to withstand the stomach's corrosive fluids long enough to preserve the contents for the intestines

Weight loss support The primary use case for Lipo-C is supporting a comprehensive weight loss program that includes diet modification and exercise

Weight loss of 15% or greater was achieved by 66.7% of participants at 9 mg and 75.0% at 10 mg, indicating robust responses across most participants rather than outlier-driven averages